Predictors of Relapse in a Bupropion Trial for Smoking Cessation in Recently-Abstinent Alcoholics: Preliminary Results Using an Aggregate Genetic Risk Score | Zendy

John E. McGeary | Zendy; Valerie S. Knopik | Zendy; John E. Hayes | Zendy; Rohan H. C. Palmer | Zendy; Peter M. Monti | Zendy; David Kalman | Zendy

Open Access

Predictors of Relapse in a Bupropion Trial for Smoking Cessation in Recently-Abstinent Alcoholics: Preliminary Results Using an Aggregate Genetic Risk Score

Author(s) -

John E. McGeary,

Valerie S. Knopik,

John E. Hayes,

Rohan H. C. Palmer,

Peter M. Monti,

David Kalman

Publication year - 2012

Publication title -

substance abuse research and treatment

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 1.027

H-Index - 22

ISSN - 1178-2218

DOI - 10.4137/sart.s8866

Subject(s) - bupropion , smoking cessation , medicine , abstinence , population , nicotine gum , nicotine , placebo , clinical psychology , psychiatry , environmental health , pathology , alternative medicine

Rates of smoking in the US population have decreased overall, but rates in some groups, including alcoholic smokers, remain high. Many newly sober alcoholics are concerned about their smoking and some attempt to quit. However, quit rates in this population are low. Prior studies suggest risk for relapse in this population may be genetically influenced and that genetic factors may moderate response to treatment.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research